Begin main content

Reports

We found 4941 result(s)

Sevelamer in Patients with End-stage Renal Disease: A Systematic Review and Economic Evaluation

Published on: November 10, 2006
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Technology Sevelamer hydrochloride oral capsule. Condition Patients with end-stage renal disease (ESRD) and hyperphosphatemia Issue Traditional (calcium-based) phosphate binders may not be perceived as suitable for controlling hyperphosphatemia in all patients because of theoretical concerns about their use, and dose-limiting hypercalcemia. Seve...

Tags

Hyperphosphatemia, End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic, ESRD, Kidney/urologic, Sevelamer Sevelamer, Renagel Renagel, Chronic Défaillance rénale chronique, Non-calcium based phosphate binders, Calcium-based phosphate binders

Portable Ultrasound Devices in Emergency Departments

Published on: March 10, 2006
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Context and Policy Issues In the emergency department (ED), prompt and accurate diagnoses made by physicians are a prerequisite for the effective and timely treatment of patients with serious illnesses and injuries. Modern diagnostic methods such as ultrasonography (U/S) and computed tomographic (CT) scanning play a role in enhancing the quality...

Tags

Medical Device, Imaging, Medical, Emergency Medicine, Ultrasound, Interventional, Ultrasound, Portable Ultrasound Devices, Emergency Departments

Catheter-Based Renal Denervation for Treatment-Resistant Hypertension

Published on: March 27, 2013
Result type: Reports

Summary Renal denervation is a minimally invasive treatment that uses low-level radio frequency energy to disrupt the renal sympathetic nerves in order to reduce blood pressure. The Symplicity Renal Denervation System (Medtronic Inc.) is the first licensed renal denervation device in Canada for treatment-resistant hypertension. Clinical data to ...

  • Project Number: EH0006

Tags

Hypertension, Hypertension, Medical devices

Point-of-Care Anticoagulation Monitoring Devices: A Better Alternative?

Published on: February 7, 2007
Result type: Reports

CADTH’s health technology assessment report on point-of-care anticoagulation monitoring devices examines the clinical and cost effectiveness of point-of-care devices used to monitor long-term oral anticoagulation therapy. How well do these devices work? Do they offer value-for-money or cost savings to the health care system? Are there factors, s...

Tags

Review Literature, Economics, Cost-Benefit Analysis, Anticoagulants, Review, Anticoagulant Drugs, Anticoagulant Agents, Medical Device, Monitoring, Ambulatory, Point of care, systematic review, Cost-effectiveness, Anticoagulant therapy, Point-of-care Monitoring Devices, CoaguChek, Coagu Chek, Pro Time, ProTime, anticoagulant, anti-coagulant, anti-coagulants, Point-of-care, Monitoring Devices, OAT, anticoagulation

Mirabegron (Myrbetriq)

Last Updated: November 27, 2013
Result type: Reports
Product Line: Common Drug Review
Generic Name: Mirabegron
Indications: Bladder, overactive

  • Brand Name: Myrbetriq
  • Manufacturer: Astellas Pharma Canada Inc.
  • Project Number: SR0363
  • Project Status: Complete
  • Submission Type: New

Riociguat (Adempas)

Last Updated: September 30, 2013
Result type: Reports
Product Line: Common Drug Review
Generic Name: Riociguat
Indications: Pulmonary hypertension, chronic thromboembolic

  • Brand Name: Adempas
  • Manufacturer: Bayer Inc.
  • Project Number: SR0353
  • Project Status: Complete
  • Submission Type: New